Holen Sie sich die Stockscreener-App
72.33
1.83%
1.30
Handel nachbörslich:
72.30
-0.03
-0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$71.03
Offen:
$72.04
24-Stunden-Volumen:
4.69M
Relative Volume:
1.16
Marktkapitalisierung:
$49.12B
Einnahmen:
$17.18B
Nettoeinkommen (Verlust:
$1.40B
KGV:
35.28
EPS:
2.05
Netto-Cashflow:
$2.59B
1W Leistung:
+1.63%
1M Leistung:
-1.69%
6M Leistung:
+15.07%
1J Leistung:
+39.82%
1-Tages-Spanne:
$70.83
$72.39
1-Wochen-Bereich:
$68.70
$73.00
52-Wochen-Spanne:
$51.25
$77.41
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Vergleichen Sie CTVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
72.33 | 48.24B | 17.18B | 1.40B | 2.59B | 2.05 |
|
NTR
Nutrien Ltd
|
56.88 | 27.23B | 25.68B | 527.00M | 839.00M | 1.07 |
|
CF
Cf Industries Holdings Inc
|
86.42 | 13.43B | 6.13B | 1.34B | 1.86B | 7.59 |
|
MOS
Mosaic Company
|
32.21 | 9.90B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
6.09 | 7.65B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
CF Industries, Corteva upgraded at Barclays on strong results, LatAm growth potential (CF:NYSE) - Seeking Alpha
Corteva Shares Rise After Barclays Upgrade - MarketScreener
Corteva’s SWOT analysis: agricultural giant’s stock faces market headwinds - Investing.com
Barclays Upgrades Corteva to Overweight From Equalweight, Adjusts Price Target to $84 From $75 - MarketScreener
Chemours, DuPont, Corteva agree to $875 million settlement over New Jersey PFAS lawsuits - Smart Water Magazine
Barclays upgrades Corteva stock rating to Overweight on strong growth outlook - Investing.com Australia
Stock Analysis | Corteva OutlookMixed Signals Amid Analyst Optimism and Weak Technicals - AInvest
Agriculture Stocks Worth WatchingAugust 11th - MarketBeat
Wells Fargo Hikes Corteva (CTVA) Price Target Affirms ‘Overweight’ Rating - MSN
Corteva Earns Relative Strength Rating Upgrade; Hits Key Threshold - Investor's Business Daily
Corteva Shares Soar on Earnings Beat and Upgraded Guidance Despite 236th Trading Volume Ranking - AInvest
Best Agriculture Stocks To Follow NowAugust 10th - MarketBeat
Corteva beats estimates with rising demand for seed, crop protection; raises outlook - MSN
RBC Capital raises Corteva stock price target to $86 on Q2 beat - Investing.com Australia
Former Corteva leader tapped as next AgriNovus CEO - Inside INdiana Business
RBC Capital Adjusts Price Target on Corteva to $86 From $85, Maintains Outperform Rating - MarketScreener
Corteva (CTVA) Stock Surges 37.6% YOY on Strong Seed & Crop Protection GrowthNews and Statistics - IndexBox
Do Wall Street Analysts Like Corteva Stock? - Barchart.com
Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings - 富途牛牛
New Buy Rating for Corteva (CTVA), the Basic Materials Giant - The Globe and Mail
Corteva Gets Hold Rating from J.P. Morgan with $70 Price Target - AInvest
Corteva Reports Strong 2025 Earnings, Raises Guidance - The Globe and Mail
Top Agriculture Stocks To Keep An Eye OnAugust 7th - MarketBeat
RBC Raises Price Target on Corteva to $86 From $85, Keeps Outperform Rating - MarketScreener
Corteva, Inc. (NYSE:CTVA) Q2 2025 Earnings Call Transcript - Insider Monkey
JPMorgan Adjusts Price Target on Corteva to $70 From $65, Maintains Neutral Rating - MarketScreener
Citigroup Adjusts Price Target on Corteva to $83 From $85, Maintains Buy Rating - MarketScreener
Corteva stock price target raised to $85 from $84 at KeyBanc - Investing.com Nigeria
Deutsche Bank Adjusts Corteva Price Target to $83 From $85, Maintains Buy Rating - MarketScreener
Oppenheimer reiterates Outperform rating on Corteva stock after strong Q2 By Investing.com - Investing.com Nigeria
Oppenheimer reiterates Outperform rating on Corteva stock after strong Q2 - Investing.com
Corteva Inc (CTVA) Q2 2025 Earnings Call Highlights: Strong EBIT - GuruFocus
Research Alert: CFRA Upgrades Opinion On Shares Of Corteva, Inc. To Buy From Hold - 富途牛牛
Corteva Tolvera % JL Farmakis IncAd from 2025-08-08 - AgUpdate
Decoding Corteva Inc (CTVA): A Strategic SWOT Insight - GuruFocus
Corteva's 58.8% Trading Volume Surge Ranks 212th as Strong Q2 Earnings Drive Mixed Investor Sentiment - AInvest
Corteva (CTVA) Gets Boost from Oppenheimer Analyst Kristen Owen with New Buy Recommendation - AInvest
Corteva Earnings Call Highlights Robust Growth Amid Challenges - TipRanks
Corteva, Inc. (CTVA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Corteva, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Corteva Q2 2025 beats earnings, raises guidance By Investing.com - Investing.com Canada
Earnings call transcript: Corteva Q2 2025 beats earnings, raises guidance - Investing.com
Corteva raises 2025 operating EBITDA guidance to $3.8B amid record first-half performance and cost improvements - MSN
BNP Paribas Exane Adjusts Corteva Price Target to $70 From $65 - MarketScreener
UBS Maintains Buy Rating on CTVA, Raises Price Target | CTVA Sto - GuruFocus
Corteva's Q2 2025: Unpacking Contradictions in Crop Protection and Seed Pricing Strategies - AInvest
Corteva Raises 2025 Operating EBITDA Guidance to $3.8B Amid Record First-Half Performance and Cost Improvements. - AInvest
UBS Maintains Buy Rating on Corteva, Raises PT to $91 - AInvest
Transcript : Corteva, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Corteva Posts $3.35B Operating EBITDA in H1 2025, Eyes $3.85B for Full Year - global-agriculture.com
Corteva beats estimates with rising demand for seed, crop protection; raises outlook (CTVA:NYSE) - Seeking Alpha
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):